DSM

DSM
Title	Diagnostic and Statistical Manual of Mental Disorders
Caption	Cover of a recent edition
Author	American Psychiatric Association
Country	United States
Language	English
Subject	Psychiatry
Publisher	American Psychiatric Association Publishing
Pub date	First edition 1952
Media type	Print, digital
Pages	varies by edition
Isbn	varies

DSM

The Diagnostic and Statistical Manual of Mental Disorders is a classification and diagnostic tool produced by the American Psychiatric Association used in clinical, research, educational, and administrative contexts across institutions such as National Institute of Mental Health, Veterans Health Administration, World Health Organization, Centers for Medicare & Medicaid Services, and academic centers like Harvard Medical School, Johns Hopkins University, Yale School of Medicine. It provides standardized criteria that influence practice in settings including Mayo Clinic, Cleveland Clinic, Oxford University, Cambridge University Press-associated programs, and regulatory frameworks like the Affordable Care Act and insurance systems including Blue Cross Blue Shield and Medicare. Developed in dialogue with professional bodies such as the American Psychological Association, World Psychiatric Association, Royal College of Psychiatrists, and stakeholder groups including National Alliance on Mental Illness, it has shaped diagnostic coding linked to systems like the International Classification of Diseases and billing standards used by institutions like Centers for Disease Control and Prevention.

History

The manual originated amid post‑World War II initiatives involving the Veterans Administration, the United States Navy, the United States Army Medical Department, and psychiatric leaders in organizations including the American Psychiatric Association and the National Institute of Mental Health. Early influences included classification exercises at institutions such as St. Elizabeths Hospital and policy discussions involving figures connected with the New Deal era and programs like the National Mental Health Act (1946). Subsequent developments intersected with controversies involving Walter Freeman and lobotomy debates, court cases in jurisdictions like Brown v. Board of Education-era civic shifts, and collaborations with research consortia at Massachusetts General Hospital, Columbia University Medical Center, and Stanford University School of Medicine. International dialogues with the World Health Organization and forums like the World Congress of Psychiatry shaped later editions.

Editions and Revisions

Major editions were promulgated by the American Psychiatric Association in serial releases that involved task forces drawing membership from institutions such as Yale School of Medicine, University of California, Los Angeles, University of Pittsburgh School of Medicine, and consultation with agencies like the National Institutes of Health. Each revision incorporated input from specialty societies including the American Academy of Child and Adolescent Psychiatry, the American Geriatrics Society, and panels convened with stakeholders from Veterans Affairs and academic centers like University of Michigan Medical School and University College London. The evolution paralleled parallel coding changes coordinated with the World Health Organization's International Classification of Diseases and administrative transitions affecting insurers such as UnitedHealthcare and governmental bodies like the Social Security Administration.

Diagnostic Criteria and Classification System

The manual's nosology was developed by committees composed of psychiatrists affiliated with universities such as Columbia University, University of Pennsylvania, Duke University School of Medicine, and specialty organizations including the American Academy of Neurology and the American Academy of Pediatrics. Criteria sets align clinical descriptions used in academic centers like Mount Sinai Health System and research protocols funded by the National Institute of Mental Health and the European Research Council. Crosswalking to codes used by agencies such as the World Health Organization and billing systems in institutions like Kaiser Permanente facilitates epidemiologic studies by teams at Johns Hopkins Bloomberg School of Public Health and longitudinal cohorts such as those managed by Framingham Heart Study collaborators.

Impact on Clinical Practice and Research

Adoption by hospitals including Cleveland Clinic, large health systems like Kaiser Permanente, and university clinics at University of California, San Francisco and University of Washington shaped training in residency programs accredited by organizations such as the Accreditation Council for Graduate Medical Education and influenced credentialing bodies like the American Board of Psychiatry and Neurology. Use in multicenter trials coordinated by consortia such as the Clinical Antipsychotic Trials of Intervention Effectiveness and funded by agencies including the National Institutes of Health and foundations like the Robert Wood Johnson Foundation structured outcome measures and regulatory submissions to agencies such as the Food and Drug Administration.

Criticisms and Controversies

Critiques emerged in debates involving scholars and clinicians from institutions like King's College London, McGill University, University of Toronto, and advocacy groups such as Mind and Samaritans. Disputes over validity, reliability, and medicalization involved commentators associated with publications in journals edited at The Lancet, JAMA Psychiatry, British Journal of Psychiatry, and panels convened by bodies like the Cochrane Collaboration. Legal and policy controversies reached forums including legislative hearings in bodies such as the United States Congress and policy reviews by the European Commission.

Cultural and Global Considerations

Global implementation engaged partnerships with the World Health Organization, national ministries linked to Department of Health and Social Care (United Kingdom), Health Canada, Ministry of Health (Australia), and regional research networks including the African Academy of Sciences and Pan American Health Organization. Cross‑cultural research from centers such as University of Hong Kong, Peking University Health Science Center, University of São Paulo, and University of Cape Town highlighted challenges in applying criteria across linguistic and cultural contexts, prompting collaborations with cultural experts from institutions like SOAS University of London and policy bodies such as the United Nations.

Category:Psychiatry